|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 4/20/05 Astro Med Inc/New 10-K 1/31/05 8:740K RR Donnelley/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 653K
2: EX-13 Letter to Shareholders HTML 10K
3: EX-21 List of Subsidiaries of the Company HTML 7K
4: EX-23.1 Consent of Independent Auditors HTML 7K
5: EX-31.1 Certification of CEO Pursuant to Rule 13A-14(A) HTML 11K
6: EX-31.2 Certification of CFO Pursuant to Rule 13A-14(A) HTML 11K
7: EX-32.1 Certification of CEO Pursuant to Rule 13A-14(B) HTML 8K
and 18
8: EX-32.2 Certification of CFO Pursuant to Rule 13A-14(B) HTML 8K
and 18
| Letter to Shareholders |
Exhibit 13
TO OUR SHAREHOLDERS
The Fiscal Year which ended January 31, 2005 (Fiscal year 2005) was a year of considerable achievement and some disappointment. Our revenues and gross profit were flat with the prior year and, because we chose to promote future growth with increased investment in Sales & Marketing and Research & Development initiatives, our net income declined to $2,710,000 from $3,217,000 in the prior year.
Our considerable achievements include expanding our domestic and international sales organization with experienced professionals, and increasing our R&D staff with outstanding engineers. Both investments will propel the Company’s sales growth. In addition, as the year ended, our development of an advanced airborne cockpit printer was attracting considerable attention from major aircraft
manufacturers and their sub-contractors. The market for these advanced avionics products is significant and although we have strong competitors, we remain confident we will continue to be a major participant in this new market for many years to come.
Our considerable achievements also include major product improvements across all product groups, including new features for which we have filed patent applications in the US and in several key foreign countries. These pending patent applications also cover some exciting, entirely new products which will be introduced in the New Year. We are very proud of the inventiveness of our engineers and believe that these new products will produce significant future revenues and profits.
THE YEAR AHEAD
For the Fiscal Year ending January 31, 2006 (Fiscal Year 2006) we are forecasting that revenues will grow to $62 million and net income to reach between $2.7 million and $3.0 million, equal to 47 cents to 51 cents per diluted share. This forecast represents revenue growth of 11% and net income growth of more than 50% from the prior year’s net income after excluding the one time $0.9 million in favorable tax treatment realized in FY2005.
We invite shareholders and investors to visit the Astro-Med corporate website at www.Astro-MedInc.com.
| /s/ Albert W. Ondis |
| Albert W. Ondis, Chairman and Chief Executive Officer |
| Everett V. Pizzuti, President and Chief Operating Officer |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 1/31/06 | 10-K | |||
| Filed on: | 4/20/05 | DEF 14A | ||
| For Period End: | 1/31/05 | |||
| List all Filings | ||||